Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Pearce

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|November 15, 1992
Comparison of Doppler and two-dimensional echocardiography for assessment of pericardial effusionJ J Schutzman, T P Obarski, G L Pearce, et al.
The American Journal of Cardiology|August 18, 2000
Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass graftingJ P Frolkis, G G Blackburn, G L Pearce, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event MonitoringK Kubota, N Kubota, G L Pearce, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 6, 2000
QT lengthening and life-threatening arrhythmias associated with fexofenadineP M Craig-McFeely, S L Freemantle, G L Pearce, et al.
European Journal of Clinical Pharmacology|January 1, 1997
A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV studyE Wager, P J Tooley, G L Pearce, et al.
Drug Safety|January 5, 2002
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring databaseD W Clark, D Layton, L V Wilton, et al.
Diabetes Care|November 25, 2000
Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysisD L Sprecher, G L Pearce, E M Park, et al.
BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoringW H Inman, N S Rawson, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilanceR D Mann, L V Wilton, G L Pearce, et al.
Epilepsia|August 1, 1997
Safety of long-term lamotrigine in epilepsyF J Mackay, L V Wilton, G L Pearce, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|November 15, 1992
Comparison of Doppler and two-dimensional echocardiography for assessment of pericardial effusionJ J Schutzman, T P Obarski, G L Pearce, et al.
The American Journal of Cardiology|August 18, 2000
Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass graftingJ P Frolkis, G G Blackburn, G L Pearce, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event MonitoringK Kubota, N Kubota, G L Pearce, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 6, 2000
QT lengthening and life-threatening arrhythmias associated with fexofenadineP M Craig-McFeely, S L Freemantle, G L Pearce, et al.
European Journal of Clinical Pharmacology|January 1, 1997
A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV studyE Wager, P J Tooley, G L Pearce, et al.
Drug Safety|January 5, 2002
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring databaseD W Clark, D Layton, L V Wilton, et al.
Diabetes Care|November 25, 2000
Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysisD L Sprecher, G L Pearce, E M Park, et al.
BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoringW H Inman, N S Rawson, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilanceR D Mann, L V Wilton, G L Pearce, et al.
Epilepsia|August 1, 1997
Safety of long-term lamotrigine in epilepsyF J Mackay, L V Wilton, G L Pearce, et al.
Pageof 5